Health Canada has issued both a Public Communication and a `Dear Healthcare Professional' letter advising of updated safety information for Invirase [saquinavir]

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1327, 2010-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Jones Pharma Incorporated has issued a `Dear Healthcare Professional' letter advising of changes to the US labelling of Levoxyl [levothyroxine sodium].

By  

Reactions Weekly, Vol. 1, Iss. 1023, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Health Canada has issued a `Dear Pharmacist' letter advising of a recall of certain sustained-release potassium replacement products

By  

Reactions Weekly, Vol. 1, Iss. 1018, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Amgen Inc. has issued a `Dear Health Care Professional' letter advising of important changes to the labelling for Aranesp

By  

Reactions Weekly, Vol. 1, Iss. 1035, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Hoffmann-La Roche has issued a "Dear Health Care Professional" letter highlighting dosing information for Tamiflu

By  

Reactions Weekly, Vol. 1, Iss. 1275, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Bristol-Myers Squibb has issued a `Dear Health Care Provider' letter advising of a change in the pregnancy category for Sustiva [efavirenz]

By  

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite